Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alphamab Oncology

http://www.alphamabonc.com/

Latest From Alphamab Oncology

As China Prices Drop, Junshi Looks To Coherus To Take PD-1 Global

After Novartis, US firm Coherus leaps into the China immuno-oncology fray by licensing rights to innovative drugs from Shanghai's Junshi.

China Deals

Affordable PD-1 From China? CStone Going Global With EQRx Onboard

As the China immuno-oncology sector becomes increasingly crowded, CStone teams up with an innovative US business partner to go global.

Commercial ImmunoOncology

Pfizer Bets $480m On CStone And Surging China Immuno-Oncology Market

The latest big pharma vote of confidence in both the China market and R&D capabilities comes amid continuing standoffs with the US over a flurry of issues including the coronavirus, national security and trade, but as the pandemic seemingly recedes in China.

China Deals

Coronavirus Update: Sinovac Latest To Report Vaccine Success In Humans

Sinovac's candidate is a more conventional inactivated vaccine, but is keeping pace with more modern approaches taken by Moderna and CanSino.

Coronavirus COVID-19 BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Alphamab Biopharmaceuticals Co., Ltd.
    • Jiangsu Alphamab Biopharmaceuticals Co., Ltd.
    • Suzhou Alphamab Co., Ltd.
UsernamePublicRestriction

Register